Authors: Fisher, B Anderson, S Tan-Chiu, E Wolmark, N Wickerham, DL Fisher, ER Dimitrov, NV Atkins, JN Abramson, N Merajver, S Romond, EH Kardinal, CG Shibata, HR Margolese, RG Farrar, WB

Citation: B. Fisher et al., Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23, J CL ONCOL, 19(4), 2001, pp. 931-942

Authors: Sloan, JA Loprinzi, CL Laurine, JA Novotny, PJ Vargas-Chanes, D Krook, JE O'Connell, MJ Kugler, JW Tirona, MT Kardinal, CG Wiesenfeld, M Tschetter, LK Hatfield, AK Schaefer, PL

Citation: Ja. Sloan et al., A simple stratification factor prognostic for survival in advanced cancer:The Good/Bad/Uncertain index, J CL ONCOL, 19(15), 2001, pp. 3539-3546

Authors: Perez, EA Hillman, DW Stella, PJ Krook, JE Hartmann, LC Fitch, TR Hatfield, AK Mailliard, JA Nair, S Kardinal, CG Ingle, JN

Citation: Ea. Perez et al., A phase II study of paclitaxel plus carboplatin as first-line chemotherapyfor women with metastatic breast carcinoma, CANCER, 88(1), 2000, pp. 124-131

Authors: Fisher, B Anderson, S DeCillis, A Dimitrov, N Atkins, JN Fehrenbacher, L Henry, PH Romond, EH Lanier, KS Davila, E Kardinal, CG Laufman, L Pierce, HI Abramson, N Keller, AM Hamm, JT Wickerham, DL Begovic, M Tan-Chiu, E Tian, W Wolmark, N

Citation: B. Fisher et al., Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25, J CL ONCOL, 17(11), 1999, pp. 3374-3388

Authors: Fisher, B Dignam, J Wolmark, N Wickerham, DL Fisher, ER Mamounas, E Smith, R Begovic, M Dimitrov, NV Margolese, RG Kardinal, CG Kavanah, MT Fehrenbacher, L Oishi, RH

Citation: B. Fisher et al., Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial, LANCET, 353(9169), 1999, pp. 1993-2000

Authors: Ingle, JN Suman, VJ Kardinal, CG Krook, JE Mailliard, JA Veeder, MH Loprinzi, CL Dalton, RJ Hartmann, LC Conover, CA Pollak, MN

Citation: Jn. Ingle et al., A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma, CANCER, 85(6), 1999, pp. 1284-1292